Clinical Trial Update: Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT) [Phase 4]

View source ↗

Summary

Clinical trial update on a Phase 4 study evaluating olmesartan medoxomil for coronary atherosclerosis and epicardial adipose tissue; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis

Drugs mentioned

• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Coronary Atherosclerosis | Phase 4 | Status: UNKNOWN